Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Operating Leases (2023 - 2025)

Historic Operating Leases for Silence Therapeutics (SLN) over the last 2 years, with Q3 2025 value amounting to $97000.0.

  • Silence Therapeutics' Operating Leases changed N/A to $97000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $97000.0, marking a year-over-year change of. This contributed to the annual value of $118000.0 for FY2023, which is N/A changed from last year.
  • As of Q3 2025, Silence Therapeutics' Operating Leases stood at $97000.0.
  • In the past 5 years, Silence Therapeutics' Operating Leases ranged from a high of $115427.1 in Q4 2023 and a low of $97000.0 during Q3 2025